Advances in the diagnosis and treatment of nonalcoholic fatty liver disease-related liver fibrosis
10.3969/j.issn.1001-5256.2020.01.042
- VernacularTitle:非酒精性脂肪性肝病肝纤维化的诊断和治疗进展
- Author:
Hongmei ZHU
1
;
Qinying WANG
Author Information
1. Shanxi Medical University, Taiyuan 030001, China
- Publication Type:Research Article
- Keywords:
non-alcoholic fatty liver disease;
liver cirrhosis;
diagnosis;
therapeutics
- From:
Journal of Clinical Hepatology
2020;36(1):178-181
- CountryChina
- Language:Chinese
-
Abstract:
Nonalcoholic fatty liver disease (NAFLD) is becoming the most common chronic liver disease in the world. From the perspective of its disease spectrum, nonalcoholic steatohepatitis (NASH) is a form of disease progression and can progress to liver fibrosis, leading to NAFLD-related liver cirrhosis and liver cancer. NASH-related liver fibrosis is closely associated with prognosis, and effective measures are urgently needed for the diagnosis and intervention of disease progression. This article summarizes the research advances in the diagnosis and treatment of NAFLD-related liver fibrosis.
